生物活性 | |||
---|---|---|---|
描述 | Neratinib (HKI-272) maleate is an orally administered, irreversible inhibitor with high selectivity for HER2 and EGFR, exhibiting IC50 values of 59 nM and 92 nM, respectively. This specificity underlines its potential therapeutic application in targeting certain cancers[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.49mL 0.30mL 0.15mL |
7.43mL 1.49mL 0.74mL |
14.86mL 2.97mL 1.49mL |
参考文献 |
---|